Immunotherapy Leads to Complete Regression in Late-Stage Breast Cancer

National Cancer Institute (NCI) researchers recently reported complete and durable regression of chemorefractory metastaticERBB2-negative and ER-positive breast cancer in a woman who received an experimental immunotherapy. Thecase report, published recently inNature Medicine, involved a 49-year-old patient whose late-stage cancer was progressing despite multiple lines of chemotherapy and hormone treatments.
Source: JAMA - Category: General Medicine Source Type: research